BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260904T140000
DTEND;TZID=Europe/Paris:20260904T180000
DTSTAMP:20260901T123003Z
CREATED:20260603T145017Z
LAST-MODIFIED:20260901T123003Z
UID:14377-1788530400-1788544800@paradigms.foundation
SUMMARY:Scientific meeting: Multiple Sclerosis - Multiple Predictors in Disease Prognostication
DESCRIPTION:The scientific meeting chaired by ParadigMS expert Maura Pugliatti will be exploring current and emerging predictors of disease progression in Multiple Sclerosis.\n\n\n\nRegistration\n\n\n\nParticipation is free of charge\, but registration is required as places are limited. Please complete the registration form to confirm your attendance. \n\n\n\n\nRegister to attend the in-person scientific meeting\n\n\n\n\nMeeting details\n\n\n\nDate: Friday\, 4 September 2026Time: 13:00-18:10Location: Palazzo Roverella\, Ferrara\, ItalyRegistration: Free of chargeCME accreditation: No CME credits available \n\n\n\nUnderstanding disease progression remains one of the greatest challenges in Multiple Sclerosis (MS) care. This scientific meeting will bring together leading international experts to examine the diverse factors that contribute to disease prognostication\, from clinical and biological markers to emerging technologies and predictive models. \n\n\n\nParticipants will explore current evidence on pathophysiology\, biomarkers\, genetic studies\, registries\, comorbidities\, imaging\, and decision-support systems\, while discussing how these insights may support more personalized management strategies for people living with MS. \n\n\n\nDepliant_MS&NO_September4_DEFDownload\n\n\n\nDownload the programme \n\n\n\nScientific committee\n\n\n\n\nMaura Pugliatti\n\n\n\nCaterina Ferri\n\n\n\nNicola Merli\n\n\n\nMassimiliano Castellazzi\n\n\n\n\nProgramme overview\n\n\n\nSession I\n\n\n\nPrognostication in Multiple Sclerosis: Pathogenesis\, Pathophysiology and Clinical Presentation \n\n\n\n14:00Multiple sclerosis progression: pathophysiology and measurementsCelia Oreja-Guevara (Spain) \n\n\n\n14:20Clinical predictors of disease progressionBart Van Wijmeersch (Belgium) \n\n\n\n14:40Biomarkers in predicting multiple sclerosis worseningLaura Airas (Finland) \n\n\n\n15:00Prognostication from genetic studiesSandra D’Alfonso (Italy) \n\n\n\n15:20Investigating disease prognosis through data collection: the Italian MS RegistryPietro Iaffaldano (Italy) \n\n\n\n15:40Microchimerism in multiple sclerosisMichele Rubini (Italy) \n\n\n\n16:00Discussion \n\n\n\nSession II\n\n\n\nPrognostication in Multiple Sclerosis: Evidence About Less Conventional Predictors \n\n\n\n16:20Prognostication from cerebrospinal fluid analysisMassimiliano Castellazzi (Italy) \n\n\n\n16:40Comorbidities in multiple sclerosis progressionCaterina Ferri (Italy) \n\n\n\n17:00The role of ultrasound in prognosis through the study of the optic nerveNicola Merli (Italy) \n\n\n\nSession III\n\n\n\nPrognostication in Multiple Sclerosis: Moving Towards Algorithms and Decisional Support Systems \n\n\n\n17:20Decisional support systems\, modelling and algorithmsMassimiliano Copetti (Italy) \n\n\n\n17:40Prognostication in multiple sclerosis: the PROMISING StudyMaura Pugliatti (Italy) \n\n\n\n18:00Discussion \n\n\n\n18:10Closing remarksMaura Pugliatti (Italy) \n\n\n\nWhy attend?\n\n\n\nThis meeting offers a comprehensive overview of established and emerging predictors of disease progression in Multiple Sclerosis\, bringing together expertise from clinical practice\, epidemiology\, genetics\, biomarker research and data science. Attendees will gain practical insights into how prognostic tools may support more informed treatment decisions and personalised patient care. \n\n\n\nUnder the auspices of\n\n\n\n\nParadigMS\n\n\n\nUniversity of Ferrara\n\n\n\nFerrara University Hospital\n\n\n\nFerrara Health District\n\n\n\nItalian Society of Neurology (SIN)\n\n\n\nItalian Association of Neuroepidemiology (AINEP)\n\n\n\n\nSponsorships
URL:https://paradigms.foundation/event/scientific-meeting-multiple-sclerosis-multiple-predictors-in-disease-prognostication/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/06/Palazzo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260905T083000
DTEND;TZID=Europe/Paris:20260905T134500
DTSTAMP:20260605T090440Z
CREATED:20260603T142911Z
LAST-MODIFIED:20260605T090440Z
UID:14355-1788597000-1788615900@paradigms.foundation
SUMMARY:ParadigMS Expert Meeting 2026
DESCRIPTION:Casa d’Este – Hotel Ferrara\, Italy\n\n\n\n\n\nPractical details\n\n\n\nDate: Saturday\, 5 September 2026Time: 08:30 -13:45Location: Casa d’Este – Hotel Ferrara\, ItalyAudience: ParadigMS expert members \n\n\n\nUpon invitation meeting only \n\n\n\nThe ParadigMS Expert Meeting 2026 will bring together international neurologists and Multiple Sclerosis (MS) experts to discuss current and emerging topics in demyelinating diseases. \n\n\n\nThe programme will focus on new therapies\, paediatric MS\, symptomatic treatment\, healthcare system impact on treatment choice\, disability progression\, BTK inhibitors\, and clinical management of Neuromyelitis Optica Spectrum Disorder (NMOSD)\, optic neuritis and MS. \n\n\n\nProgramme overview\n\n\n\n08:30–08:45Introduction to the meetingCelia Oreja-Guevara \n\n\n\n08:45–09:15New therapies in MGAndrew Chan\, Maura Pugliatti \n\n\n\n09:15–09:45Paediatric MSMagd Zakaria\, Carlo Pozzilli \n\n\n\n09:45–10:15Symptomatic therapies in Multiple SclerosisVeronica Popescu\, Bart Van Wijmeersch\, Carlo Pozzilli\, Melinda Magyari\, Patrick Vermersch \n\n\n\n10:15–10:45Coffee break \n\n\n\n10:45–11:20How healthcare system classification impacts treatment choice in Multiple SclerosisThomas Berger\, Tjalf Ziemssen\, Nikolaos Grigoriadis\, Magd Zakaria\, Melinda Magyari \n\n\n\n11:20–11:40Prognosis in Multiple SclerosisMaura Pugliatti \n\n\n\n11:40–12:00Uncovering Disability Progression in People with Multiple Sclerosis: A Practical GuideBart Van Wijmeersch\, ParadigMS Office team \n\n\n\n12:00–12:40Treatment landscape and approaches in the era of BTK inhibitors \n\n\n\n12:40–13:10Lunch \n\n\n\n13:10–13:30Diagnosis and clinical management of NMO/Optic Neuritis and MSKazuo Fujihara\, Celia Oreja-Guevara\, Melinda Magyari \n\n\n\n13:30–13:45ClosingCelia Oreja-Guevara \n\n\n\n\n	\n\n\n\n\nThe ParadigMS Expert Meeting will be sponsored by Roche\, Sandoz and Sanofi
URL:https://paradigms.foundation/event/paradigms-expert-meeting-2026-ferrara-italy/
LOCATION:Ferrara\, Italy
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/06/Castello-Estense.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260929T163000
DTEND;TZID=Europe/Paris:20260929T173000
DTSTAMP:20260923T162319Z
CREATED:20260901T100648Z
LAST-MODIFIED:20260923T162319Z
UID:14730-1790699400-1790703000@paradigms.foundation
SUMMARY:Live Webinar on Paediatric Multiple Sclerosis
DESCRIPTION:Join this ParadigMS live webinar dedicated to Paediatric Multiple Sclerosis (MS) and explore expert perspectives on the challenges of recognising\, diagnosing and managing MS in children and adolescents. \n\n\n\nThe session will bring together leading experts to discuss current clinical considerations and provide practical insights relevant to neurologists and healthcare professionals involved in MS care. \n\n\n\nKey Highlights\n\n\n\n\nEpidemiology\, genetic and environmental factors in paediatric MS.\n\n\n\nDisease course\, smouldering disease and risk of persistent disability.\n\n\n\nNew diagnostic criteria and differential diagnosis\, including NMOSD and MOGAD.\n\n\n\nCSF\, imaging and blood biomarkers.\n\n\n\nNeuropsychological performance\, quality of life and psychological issues.\n\n\n\nPharmacological therapies and evolving treatment approaches.\n\n\n\nLong-term monitoring and support for younger patients and their families.\n\n\n\nQ&A on key clinical challenges.\n\n\n\n\nMore information & Learning Objectives to come soon \n\n\n\nFind out more about the speakers: \n\n\n\nSpeakers\n\n\n\n\nThais Armangué \n\n\n\nCarlo Pozzilli\n\n\n\n\nModerator\n\n\n\n\nValeria Pozzilli\n\n\n\n\nRegister\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages (offered by Zoom platform). \n\n\n\nWhy participate?\n\n\n\n\nExplore the key clinical features of paediatric Multiple Sclerosis (MS)\n\n\n\nStrengthen diagnostic confidence in children and adolescents with suspected MS\n\n\n\nReview important differential diagnoses and challenges specific to paediatric-onset disease\n\n\n\nDiscuss current approaches to treatment selection and long-term disease management\n\n\n\nGain expert perspectives on monitoring disease activity and supporting care across the transition to adulthood\n\n\n\n\nWho should join?\n\n\n\n\nNeurologists and paediatric neurologists with an interest in Multiple Sclerosis\n\n\n\nMS specialists and neurologists in training\n\n\n\nNurses and other healthcare professionals involved in MS care\n\n\n\nHealthcare professionals involved in the diagnosis or management of paediatric demyelinating disorders\n\n\n\n\nQuestions and comments\n\n\n\nShould you have specific questions\, you would like to see discussed\, please share them with learning@paradigms.foundation now\, so the speakers could relate to them in their presentations.  \n\n\n\nYou will also have the opportunity to ask questions in person and participate in discussion during the webinar and the Q&A session. \n\n\n\nTechnology used\n\n\n\nThe webinar takes place via Zoom\, you will receive connection details upon registration. \n\n\n\nDate and time\n\n\n\nThe session will be held on Tuesday\, 29th September 2026 from 16:30 to 17:30 CEST. \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCarlo Pozzilli\n\n\n\n\nProfessor of Clinical Neuroscience at University of Rome “La Sapienza” \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThaìs Armangué\n\n\n\n\nHead of the Department and attending in the Paediatric Neuroimmunology Unit at SJD Barcelona Children’s Hospital \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nValeria Pozzilli\n\n\n\n\nNeurologist and researcher\, Queen Square MS Centre\, UCL Queen Square Institute of Neurology\, University College London\, United Kingdom \n\n\n\n\n\n\n\nRegistration\n\n\n\nRegistration is necessary and can be completed by clicking the button on top of this page or here: \n\n\n\n \n\n\n\n\nRegister now\n\n\n\n\nFunding\n\n\n\nThis webinar was organized with the financial support of Roche. \n\n\n\nRoche has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/live-webinar-on-paediatric-multiple-sclerosis/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/09/PDMS-Live-webinar-banner-1080x655px_1.jpg
END:VEVENT
END:VCALENDAR